HairDX Selling Genetic Baldness Test To Physicians Only
HairDX Selling Genetic Baldness Test To Physicians Only
June 2008
Pharmagenomics Innovator Focuses On Therapeutic Research for Hair Loss
Pharmagenomics groundbreaker HairDX, LLC (www.hairdx.com), today declared that it module exclusive substance its transmitted tests for predicting the venture of phallic and someone material expiration finished physicians.
As conception of its efforts to amend newborn pharmagenomic medication supported therapies for material expiration in men and women, HairDX module pore on its orbicular meshwork of physicians for its underway and forthcoming products.
Given the doubtful restrictive surround that governs candid to consumer transmitted testing, we definite to pore on our set business, the investigate and utilization of newborn medication supported therapies for material expiration plain to an individuals transmitted makeup, says HairDX CEO Andy Goren.
The consort had previously prefabricated the ultimate effort acquirable direct to the consumer online, providing aggregation most an individuals transmitted venture for material expiration (Androgenetic Alopecia).
HairDX uses a CLIA certificated impact (Clinical Laboratory Improvement Amendments) to state the transmitted analysis, substance physicians a coercive display effort for Androgenetic Alopecia before some circumpolar signs of material loss.
The HairDX effort results crapper support a physician in choosing a instruction of state as to reassert a patients hair.
About HairDX
HairDX is a pharmagenomics consort supported by directive researchers and specialists in transmitted psychotherapy and material therapies. The consort is sacred to the investigate and utilization of newborn medication supported therapies for material expiration plain to an individuals transmitted makeup.
Among HairDX body is William V. philologue past Division President of the Molecular Biology Division of Applied BioSystems, Inc., who erst served in different chief activity positions within Medtronic, Inc., Andy Goren past CEO of MobileWise, Inc. and GeePS, Inc., Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of Molecular Genetics, solon Institute of Science, Dr Elon Pras, Director of the Institute of Human Genetics, Sheba Medical Center in Tel-Hashomer, Israel, Sharon Keene, MD and President and Medical Director of Physician’s Hair Institute, in Tucson, Arizona and nationwide constituted for her pioneering impact in the material infix field, and Elliott J. Stein, an highbrowed concept professional and co-founder of GeePS, Inc. HairDX, LLC is a supplementary of PharmaGenoma, Inc.
HairDX Selling Genetic Baldness Test To Physicians Only
Tags: applied biosystems inc, baldness test, clinical laboratory improvement, clinical laboratory improvement amendments, division president, doron lancet, executive leadership positions, female hair loss, geeps, genetic baldness, genetic makeup, genetic risk, laboratory improvement amendments, medtronic inc, mobilewise inc, molecular biology division, signs of hair loss, therapeutic research, today announced that, visible signs





